We generated CDADC1-deficient variants of A-549, H1299, and KP-4 human cell lines, representing lung adenocarcinoma, highly proliferative p53-deficient large-cell lung carcinoma, and aggressive pancreatic ductal adenocarcinoma, respectively. This evidence concerns the gene CDADC1 and lung adenocarcinoma.